Potentiation of the vascular response to kinins by inhibition of myocardial kininases

Hypertension

Volumn 35, Issue 1, 2000, Pages 32-

  Dendorfer, Andreas ^a   Wolfrum, Sebastian ^a   Schäfer, Ulrich ^a   Stewart, John M ^a   Inamura, Noriaki ^a   Dominiak, Peter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Angiotensin converting enzyme; Bradykinin; Heart; Rats; Receptor

Indexed keywords

8 [2,6 DICHLORO 3 [N [4 (N METHYLCARBAMOYL)CINNAMAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYL 4 (2 PYRIDYLMETHOXY)QUINOLINE; AMINOPEPTIDASE P; B 6014; BRADYKININ; BRADYKININ B2 RECEPTOR AGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; KININ; KININASE; MERCAPTOETHANOL; RAMIPRILAT; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VESSEL REACTIVITY; DESENSITIZATION; DRUG POTENCY; DRUG STABILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; VASODILATATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; DRUG SYNERGISM; HEART; KINETICS; MALE; MERCAPTOETHANOL; MYOCARDIUM; OLIGOPEPTIDES; PERFUSION; QUINOLINES; RAMIPRIL; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; VASODILATION;

EID: 0033956857     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.35.1.32     Document Type: Article

References (30)

1. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995; 47:25-49.
2. Bönner G, Preis S, Schunk U, Wagmann M, Chrosch R, Toussaint C. Effect of bradykinin on arteries and veins in systemic and pulmonary circulation. J Cardiovasc Pharmacol. 1992; 20(suppl 9):S21-S27.
3. Mombouli JV, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res. 1992; 71:137-144.
4. Ryan JW, Berryer P, Chung AY, Sheffy DH. Characterization of rat pulmonary vascular aminopeptidase P in vivo: role in the inactivation of bradykinin. J Pharmacol Exp Ther. 1994; 269:941-947.
5. Zacest R, Oparil S, Talamo RC. Studies of plasma bradykininases using radiolabelled substrates. Aust J Exp Biol Med Sci. 1974; 52:601-606.
6. Dendorfer A, Wolfrum S, Wellhöner P, Korsman K, Dominiak P. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart. Br J Pharmacol. 1997; 122:1179-1187.
7. Palmieri FE, Bausback HH, Churchill L, Ward PE. Kinin and enkephalin conversion by an endothelial, plasma membrane carboxypeptidase. Biochem Pharmacol. 1986; 35:2749-2756.
8. Graf K, Koehne P, Gräfe M, Zhang M, Auch-Schwelk W, Fleck E. Regulation and differential expression of neutral endopeptidase 24.11 in human endothelial cells. Hypertension. 1995; 26:230-235.
9. Pellacani A, Brunner HR, Nussberger J. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin Sci (Colch). 1994; 87:567-574.
10. Auch-Schwelk W, Bossaller C, Claus M, Graf K, Gräfe M, Fleck E. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries. J Cardiovasc Pharmacol. 1992; 20(suppl 9):S62-S67.
11. Hecker M, Pörsti I, Bara AT, Busse R. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level. Br J Pharmacol. 1994; 111:238-244.
12. Auch-Schwelk W, Bossaller C, Claus M, Graf K, Gräfe M, Fleck E. ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin. Cardiovasc Res. 1993; 27:312-317.
13. Minshall RD, Erdös EG, Vogel SM. Angiotensin I-converting enzyme inhibitors potentiate bradykinin’s inotropic effects independently of blocking its inactivation. Am J Cardiol. 1997; 80:132A-136A.
14. 2 receptors and angiotensin I-converting enzyme in CHO cells. Circ Res. 1997; 81:848-856.
15. Hecker M, Blaukat A, Bara AT, Müller-Esterl W, Busse R. ACE inhibitor potentiation of bradykinin-induced venoconstriction. Br J Pharmacol. 1997; 121:1475-1481.
16. 2 receptor antagonist, FR165649, and agonist, FR190997. Br J Pharmacol. 1998; 124:441-446.
17. Vavrek RJ, Gera L, Stewart JM. Pseudopeptide analogs of bradykinin and bradykinin antagonists. Agents Actions Suppl. 1992; 38:565-571.
18. Roberts RA, Gullick WJ. Bradykinin receptors undergo ligand-induced desensitization. Biochemistry. 1990; 29:1975-1979.
19. 2 receptors and angiotensin-converting enzyme from guinea pig lung membranes. Biochim Biophys Acta. 1994; 1191:109-116.
20. 2 receptor in caveolae. J Cell Sci. 1998; 111:917-928.
21. 2 bradykinin receptors and the receptor-coupled G alpha subunits G alpha q and G alpha i in caveolae in DDT1 MF-2 smooth muscle cells. J Biol Chem. 1997; 272:17858-17866.
22. Roscher AA, Manganiello VC, Jelsema CL, Moss J. Autoregulation of bradykinin receptors and bradykinin-induced prostacyclin formation in human fibroblasts. J Clin Invest. 1984; 74:552-558.
23. 2 kinin receptor-mediated internalization of bradykinin in DDT1 MF-2 smooth muscle cells is paralleled by sequestration of the occupied receptors. Arch Biochem Biophys. 1993; 301:336-344.
24. 2 receptor from human fibroblasts. J Biol Chem. 1996; 271:32366-32374.
25. 3H]bradykinin dissociates slowly. J Biol Chem. 1990; 265:9621-9627.
26. 2 receptor. J Biol Chem. 1998; 273:1309-1315.
27. Kitamura S, Carbini LA, Carretero OA, Simmons WH, Scicli AG. Potentiation by aminopeptidase P of blood pressure response to bradykinin. Br J Pharmacol. 1995; 114:6-7.
28. Ryan JW, Papapetropoulos A, Ju H, Denslow ND, Antonov A, Virmani R, Kolodgie FD, Gerrity RG, Catravas JD. Aminopeptidase P is disposed on human endothelial cells. Immunopharmacology. 1996; 32:149-152.
29. Venema RC, Ju H, Zou R, Venema VJ, Ryan JW. Cloning and tissue distribution of human membrane-bound aminopeptidase P. Biochim Biophys Acta. 1997; 1354:45-48.
30. Orawski AT, Susz JP, Simmons WH. Metabolism of bradykinin by multiple coexisting membrane-bound peptidases in lung: techniques for investigating the role of each peptidase using specific inhibitors. Adv Exp Med Biol. 1989; 247B:355-364.